Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5714274 | European Annals of Otorhinolaryngology, Head and Neck Diseases | 2017 | 4 Pages |
Abstract
Primary TL/TPL remains the gold standard treatment for T4 larynx or hypopharynx cancer. It provides satisfactory oncologic and functional outcomes.
Related Topics
Health Sciences
Medicine and Dentistry
Otorhinolaryngology and Facial Plastic Surgery
Authors
M. Roux, O. Dassonville, M. Ettaiche, E. Chamorey, G. Poissonnet, A. Bozec,